Citadel Advisors - GALENA BIOPHARMA INC ownership

GALENA BIOPHARMA INC's ticker is and the CUSIP is 363256908. A total of 2 filers reported holding GALENA BIOPHARMA INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of GALENA BIOPHARMA INC
ValueSharesWeighting
Q2 2016$25,000
-58.3%
54,500
+23.6%
0.00%
Q1 2016$60,000
+57.9%
44,100
+71.6%
0.00%
Q4 2015$38,000
-17.4%
25,700
-12.6%
0.00%
Q3 2015$46,000
+24.3%
29,400
+36.1%
0.00%
Q2 2015$37,000
+19.4%
21,600
-1.8%
0.00%
Q1 2015$31,000
-41.5%
22,000
-37.1%
0.00%
Q4 2014$53,000
-62.1%
35,000
-48.4%
0.00%
Q3 2014$140,000
-58.2%
67,800
-38.0%
0.00%
Q2 2014$335,000
+129.5%
109,400
+87.3%
0.00%
Q1 2014$146,000
-30.8%
58,400
+37.4%
0.00%
Q4 2013$211,000
+219.7%
42,500
+47.1%
0.00%
Q3 2013$66,000
+20.0%
28,900
+16.1%
0.00%
Q2 2013$55,00024,9000.00%
Other shareholders
GALENA BIOPHARMA INC shareholders Q3 2014
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 835,500$1,721,0000.03%
Citadel Advisors 67,800$140,0000.00%
View complete list of GALENA BIOPHARMA INC shareholders